Tampa-based Florida Orthopaedic Institute surgeon Christopher Baker, MD, has performed the first surgeries using Anika Therapeutics' Integrity Implant System, which is intended to promote healing in rotator cuff repair and other tendon procedures using a hyaluronic acid-based scaffold with bone and tendon fixation components and single use arthroscopic delivery instruments.
The system was cleared by the FDA in August and is expected to see a full market release in the first quarter of 2024, according to a Nov. 28 press release.
The Integrity implant is a flexible, knitted, HA-based scaffold that provides improved dry and wet strength and regenerative capacity over first-generation collagen patches. It supports regenerative healing through improved cell infiltration, tissue remodeling and tendon thickening.
The system demonstrates greater regenerative capacity as early as 12 weeks post-implantation. At 26 weeks, the Integrity system forms a new network of tendon tissues.